{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:05:42Z","timestamp":1784739942934,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Shaanxi Province Key Research and Development Plan Project","award":["2024SF-YBXM-145"],"award-info":[{"award-number":["2024SF-YBXM-145"]}]},{"name":"Postdoctoral Fellowship Program of China Postdoctoral Science Foundation","award":["GZC20252386"],"award-info":[{"award-number":["GZC20252386"]}]},{"DOI":"10.13039\/501100002858","name":"the China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2025M783941"],"award-info":[{"award-number":["2025M783941"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82374095"],"award-info":[{"award-number":["82374095"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Shaanxi Province Science Fund for Distinguished Young Scholars","award":["2023-JC-JQ-59"],"award-info":[{"award-number":["2023-JC-JQ-59"]}]},{"name":"the Shaanxi Province Science and Technology Development Plan Project","award":["2022ZDLSF05-05"],"award-info":[{"award-number":["2022ZDLSF05-05"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Non-small cell lung cancer (NSCLC) patients often develop resistance to first-line etoposide\/cisplatin (EP) chemotherapy. However, available studies only focus on single-agent resistance to either etoposide or cisplatin in NSCLC. Hence, a notable knowledge gap exists in terms of the mechanisms underlying multidrug resistance, particularly within a system that recapitulates EP resistance in NSCLC. This emphasizes an urgent need for new strategies to tackle this challenge.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study established a chemotherapy-resistant xenograft mouse model that mimicked the clinical chemotherapy regimens used for patients with NSCLC and aimed to explore the molecular mechanisms that contribute to chemotherapy resistance in NSCLC. The key protein that regulates chemotherapy resistance in NSCLC were identified through proteomics and co-immunoprecipitation mass spectrometry (Co-IP\/MS) analyses, and revealed its regulatory mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This study identified glutamine-fructose-6-phosphate transaminase 2 (GFAT2,) as a key driver of resistance, upregulated in chemoresistant NSCLC cells. GFAT2 critically regulates the hexosamine biosynthetic pathway (HBP), enhancing uridine diphosphate-GlcNAc (UDP-GlcNAc) synthesis and overall O-GlcNAcylation. Specifically, GFAT2 augments O-GlcNAcylation of heat shock protein family D member 1 (HSPD1) at residue T320. This modification stabilizes HSPD1 by blocking its tripartite motif containing 21 (TRIM21)-mediated ubiquitination and degradation. Stabilized HSPD1 subsequently activates anti-apoptotic signaling, promoting cell survival during chemotherapy. Crucially, knockdown of either GFAT2 or HSPD1 restored chemosensitivity in models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings elucidate the GFAT2\/HSPD1 axis and O-GlcNAcylation as pivotal metabolic mechanisms underlying EP resistance, identifying them as promising therapeutic targets to overcome chemoresistance in NSCLC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-026-03674-x","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T03:06:09Z","timestamp":1771902369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["GFAT2-mediated HSPD1 O-GlcNAcylation drives chemotherapy resistance in non-small cell lung cancer"],"prefix":"10.1186","volume":"45","author":[{"given":"Man","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeren","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longyu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"issue":"1","key":"3674_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"Cancer J Clin"},{"issue":"4","key":"3674_CR2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/annonc\/mdx009","volume":"28","author":"J Liang","year":"2017","unstructured":"Liang J, Bi N, Wu S, Chen M, Lv C, Zhao L, et al. Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial. Ann Oncol. 2017;28(4):777\u201383.","journal-title":"Ann Oncol"},{"issue":"1","key":"3674_CR3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12964-020-00653-3","volume":"18","author":"Q Dong","year":"2020","unstructured":"Dong Q, Zhou C, Ren H, Zhang Z, Cheng F, Xiong Z, et al. Lactate-induced MRP1 expression contributes to metabolism-based etoposide resistance in non-small cell lung cancer cells. Cell Communication Signal. 2020;18(1):167\u201384.","journal-title":"Cell Communication Signal"},{"issue":"6","key":"3674_CR4","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.7150\/thno.51797","volume":"11","author":"D Wang","year":"2021","unstructured":"Wang D, Zhao C, Xu F, Zhang A, Jin M, Zhang K, et al. Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2. Theranostics. 2021;11(6):2860\u201375.","journal-title":"Theranostics"},{"issue":"1","key":"3674_CR5","doi-asserted-by":"publisher","first-page":"2223377","DOI":"10.1080\/15384047.2023.2223377","volume":"24","author":"H Chen","year":"2023","unstructured":"Chen H, Wang L, Liu J, Wan Z, Zhou L, Liao H, et al. LncRNA ITGB2-AS1 promotes cisplatin resistance of non-small cell lung cancer by inhibiting ferroptosis via activating the FOSL2\/NAMPT axis. Cancer Biol Ther. 2023;24(1):2223377\u201389.","journal-title":"Cancer Biol Ther"},{"issue":"6487","key":"3674_CR6","doi-asserted-by":"publisher","first-page":"eaaw5473","DOI":"10.1126\/science.aaw5473","volume":"368","author":"B Faubert","year":"2020","unstructured":"Faubert B, Solmonson A, DeBerardinis RJ. Metabolic reprogramming and cancer progression. Science. 2020;368(6487):eaaw5473\u201383.","journal-title":"Science"},{"key":"3674_CR7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2021.01.010","volume":"503","author":"C Lam","year":"2021","unstructured":"Lam C, Low JY, Tran PT, Wang H. The hexosamine biosynthetic pathway and cancer: Current knowledge and future therapeutic strategies. Cancer Lett. 2021;503:11\u20138.","journal-title":"Cancer Lett"},{"issue":"12","key":"3674_CR8","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41422-023-00848-6","volume":"33","author":"YL Ai","year":"2023","unstructured":"Ai YL, Wang WJ, Liu FJ, Fang W, Chen HZ, Wu LZ, et al. Mannose antagonizes GSDME-mediated pyroptosis through AMPK activated by metabolite GlcNAc-6P. Cell Res. 2023;33(12):904\u201322.","journal-title":"Cell Res"},{"issue":"5","key":"3674_CR9","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.molcel.2014.04.026","volume":"54","author":"CM Ferrer","year":"2014","unstructured":"Ferrer CM, Lynch TP, Sodi VL, Falcone JN, Schwab LP, Peacock DL, et al. O-GlcNAcylation regulates cancer metabolism and survival stress signaling via regulation of the HIF-1 pathway. Mol Cell. 2014;54(5):820\u201331.","journal-title":"Mol Cell"},{"issue":"10","key":"3674_CR10","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.ccell.2022.08.012","volume":"40","author":"Q Shi","year":"2022","unstructured":"Shi Q, Shen Q, Liu Y, Shi Y, Huang W, Wang X, et al. Increased glucose metabolism in TAMs fuels O-GlcNAcylation of lysosomal Cathepsin B to promote cancer metastasis and chemoresistance. Cancer Cell. 2022;40(10):1207\u201322.","journal-title":"Cancer Cell"},{"issue":"10","key":"3674_CR11","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1038\/s41418-022-00984-3","volume":"29","author":"X He","year":"2022","unstructured":"He X, Li Y, Chen Q, Zheng L, Lou J, Lin C, et al. O-GlcNAcylation and stablization of SIRT7 promote pancreatic cancer progression by blocking the SIRT7-REG\u03b3 interaction. Cell Death Differ. 2022;29(10):1970\u201381.","journal-title":"Cell Death Differ"},{"issue":"4","key":"3674_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s43018-022-00354-5","volume":"3","author":"J Li","year":"2022","unstructured":"Li J, Ye Y, Liu Z, Zhang G, Dai H, Li J, et al. Macrophage mitochondrial fission improves cancer cell phagocytosis induced by therapeutic antibodies and is impaired by glutamine competition. Nat Cancer. 2022;3(4):453\u201370.","journal-title":"Nat Cancer"},{"key":"3674_CR13","doi-asserted-by":"publisher","first-page":"100888","DOI":"10.1016\/j.drup.2022.100888","volume":"65","author":"B Parma","year":"2022","unstructured":"Parma B, Wurdak H, Ceppi P. Harnessing mitochondrial metabolism and drug resistance in non-small cell lung cancer and beyond by blocking heat-shock proteins. Drug Resist Updates. 2022;65:100888\u2013901.","journal-title":"Drug Resist Updates"},{"issue":"8","key":"3674_CR14","doi-asserted-by":"publisher","first-page":"e202300648","DOI":"10.1002\/cmdc.202300648","volume":"19","author":"R Obermann","year":"2024","unstructured":"Obermann R, Yemane B, Jarvis C, Franco FM, Kyriukha Y, Nolan W, et al. Small molecule antagonists of the DNA repair ERCC1\/XPA protein-protein interaction. ChemMedChem. 2024;19(8):e202300648\u201355.","journal-title":"ChemMedChem"},{"issue":"1\u20132","key":"3674_CR15","first-page":"20","volume":"28","author":"D Kaloni","year":"2022","unstructured":"Kaloni D, Diepstraten ST, Strasser A, Kelly GL. BCL-2 protein family: attractive targets for cancer therapy. Apoptosis. 2022;28(1\u20132):20\u201338.","journal-title":"Apoptosis"},{"issue":"30","key":"3674_CR16","doi-asserted-by":"publisher","first-page":"e2202993","DOI":"10.1002\/advs.202202993","volume":"9","author":"X Li","year":"2022","unstructured":"Li X, Peng X, Zhang C, Bai X, Li Y, Chen G, et al. Bladder cancer-derived small extracellular vesicles promote tumor angiogenesis by inducing HBP\u2010related metabolic reprogramming and SerRS O\u2010GlcNAcylation in endothelial cells. Adv Sci. 2022;9(30):e2202993\u20133015.","journal-title":"Adv Sci"},{"issue":"8","key":"3674_CR17","doi-asserted-by":"publisher","first-page":"e144703","DOI":"10.1172\/JCI144703","volume":"131","author":"J Xiang","year":"2021","unstructured":"Xiang J, Chen C, Liu R, Gou D, Chang L, Deng H, et al. Gluconeogenic enzyme PCK1 deficiency promotes CHK2 O-GlcNAcylation and hepatocellular carcinoma growth upon glucose deprivation. J Clin Investig. 2021;131(8):e144703\u201318.","journal-title":"J Clin Investig"},{"issue":"8","key":"3674_CR18","doi-asserted-by":"publisher","first-page":"e102166","DOI":"10.15252\/embj.2019102166","volume":"39","author":"B Maffei","year":"2020","unstructured":"Maffei B, Laverri\u00e8re M, Wu Y, Triboulet S, Perrinet S, Duchateau M, et al. Infection-driven activation of transglutaminase 2 boosts glucose uptake and hexosamine biosynthesis in epithelial cells. EMBO J. 2020;39(8):e102166\u201384.","journal-title":"EMBO J"},{"key":"3674_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.canlet.2020.12.020","volume":"502","author":"F Paredes","year":"2021","unstructured":"Paredes F, Williams HC, Martin SA. Metabolic adaptation in hypoxia and cancer. Cancer Lett. 2021;502:133\u201342.","journal-title":"Cancer Lett"},{"issue":"13","key":"3674_CR20","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1158\/0008-5472.CAN-22-3059","volume":"83","author":"Z Lin","year":"2023","unstructured":"Lin Z, Li J, Zhang J, Feng W, Lu J, Ma X, et al. Metabolic reprogramming driven by IGF2BP3 promotes acquired resistance to EGFR inhibitors in non\u2013small cell lung cancer. Cancer Res. 2023;83(13):2187\u2013207.","journal-title":"Cancer Res"},{"issue":"1","key":"3674_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12974-023-02944-1","volume":"20","author":"J Park","year":"2023","unstructured":"Park J, Kim DY, Hwang GS, Han IO. Repeated sleep deprivation decreases the flux into hexosamine biosynthetic pathway\/O-GlcNAc cycling and aggravates Alzheimer\u2019s disease neuropathology in adult zebrafish. J Neuroinflamm. 2023;20(1):257\u201376.","journal-title":"J Neuroinflamm"},{"issue":"6","key":"3674_CR22","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1007\/s00125-003-1122-8","volume":"46","author":"C Weigert","year":"2003","unstructured":"Weigert C, Friess U, Brodbeck K, H\u00e4ring HU, Schleicher ED. Glutamine: fructose-6-phosphate aminotransferase enzyme activity is necessary for the induction of TGF-beta1 and fibronectin expression in mesangial cells. Diabetologia. 2003;46(6):852\u201355.","journal-title":"Diabetologia"},{"issue":"12","key":"3674_CR23","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/s42255-020-00316-0","volume":"2","author":"J Kim","year":"2020","unstructured":"Kim J, Lee HM, Cai F, Ko B, Yang C, Lieu EL, et al. The hexosamine biosynthesis pathway is a targetable liability in KRAS\/LKB1 mutant lung cancer. Nat Metabolism. 2020;2(12):1401\u201312.","journal-title":"Nat Metabolism"},{"issue":"2","key":"3674_CR24","doi-asserted-by":"publisher","first-page":"805","DOI":"10.7150\/thno.50230","volume":"11","author":"J Hu","year":"2021","unstructured":"Hu J, Gao Q, Yang Y, Xia J, Zhang W, Chen Y, et al. Hexosamine biosynthetic pathway promotes the antiviral activity of SAMHD1 by enhancing O-GlcNAc transferase-mediated protein O-GlcNAcylation. Theranostics. 2021;11(2):805\u201323.","journal-title":"Theranostics"},{"issue":"11","key":"3674_CR25","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.cmet.2023.09.009","volume":"35","author":"P Zhou","year":"2023","unstructured":"Zhou P, Chang WY, Gong DA, Xia J, Chen W, Huang LY, et al. High dietary fructose promotes hepatocellular carcinoma progression by enhancing O-GlcNAcylation via microbiota-derived acetate. Cell Metabol. 2023;35(11):1961\u201375.","journal-title":"Cell Metabol"},{"issue":"4","key":"3674_CR26","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1089\/dna.2018.4447","volume":"38","author":"S Gao","year":"2019","unstructured":"Gao S, Miao Y, Liu Y, Liu X, Fan X, Lin Y, et al. Reciprocal regulation between O-GlcNAcylation and \u03b2-Catenin facilitates cell viability and inhibits apoptosis in liver cancer. DNA Cell Biol. 2019;38(4):286\u201396.","journal-title":"DNA Cell Biol"},{"issue":"4","key":"3674_CR27","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41401-023-01218-z","volume":"45","author":"CC Zhang","year":"2024","unstructured":"Zhang CC, Li Y, Jiang CY, Le QM, Liu X, Ma L, et al. O-GlcNAcylation mediates H2O2-induced apoptosis through regulation of STAT3 and FOXO1. Acta Pharmacol Sin. 2024;45(4):714\u201327.","journal-title":"Acta Pharmacol Sin"},{"issue":"Pt 1","key":"3674_CR28","doi-asserted-by":"publisher","first-page":"130351","DOI":"10.1016\/j.ijbiomac.2024.130351","volume":"264","author":"Z Zhu","year":"2024","unstructured":"Zhu Z, Li S, Yin X, Sun K, Song J, Ren W, et al. Review: Protein O-GlcNAcylation regulates DNA damage response: A novel target for cancer therapy. Int J Biol Macromol. 2024;264(Pt 1):130351\u201362.","journal-title":"Int J Biol Macromol"},{"key":"3674_CR29","doi-asserted-by":"publisher","first-page":"101150","DOI":"10.1016\/j.drup.2024.101150","volume":"77","author":"X Zeng","year":"2024","unstructured":"Zeng X, Chen Z, Zhu Y, Liu L, Zhang Z, Xiao Y, et al. O-GlcNAcylation regulation of RIPK1-dependent apoptosis dictates sensitivity to sunitinib in renal cell carcinoma. Drug Resist Updates. 2024;77:101150\u201365.","journal-title":"Drug Resist Updates"},{"issue":"22","key":"3674_CR30","doi-asserted-by":"publisher","first-page":"8988","DOI":"10.1158\/0008-5472.CAN-10-2225","volume":"70","author":"JC Ghosh","year":"2010","unstructured":"Ghosh JC, Siegelin MD, Dohi T, Altieri DC. Heat shock protein 60 regulation of the mitochondrial permeability transition pore in tumor cells. Cancer Res. 2010;70(22):8988\u201393.","journal-title":"Cancer Res"},{"issue":"8","key":"3674_CR31","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1074\/jbc.M705904200","volume":"283","author":"JC Ghosh","year":"2008","unstructured":"Ghosh JC, Dohi T, Kang BH, Altieri DC. Hsp60 regulation of tumor cell apoptosis. J Biol Chem. 2008;283(8):5188\u201394.","journal-title":"J Biol Chem"},{"issue":"1","key":"3674_CR32","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/cells9010023","volume":"9","author":"YH Huang","year":"2019","unstructured":"Huang YH, Yeh CT. Functional compartmentalization of HSP60-survivin interaction between mitochondria and cytosol in cancer cells. Cells. 2019;9(1):23\u201334.","journal-title":"Cells"},{"issue":"8","key":"3674_CR33","doi-asserted-by":"publisher","first-page":"e0074924","DOI":"10.1128\/spectrum.00749-24","volume":"12","author":"C Zhu","year":"2024","unstructured":"Zhu C, Duan Y, Dong J, Jia H, Zhang L, Xing A, et al. Quantitative analysis of the lysine acetylome reveals the role of SIRT3-mediated HSP60 deacetylation in suppressing intracellular Mycobacterium tuberculosis survival. Microbiol Spectr. 2024;12(8):e0074924\u201341.","journal-title":"Microbiol Spectr"},{"issue":"3","key":"3674_CR34","doi-asserted-by":"publisher","first-page":"e59610","DOI":"10.1371\/journal.pone.0059610","volume":"8","author":"H Tang","year":"2013","unstructured":"Tang H, Tian E, Liu C, Wang Q, Deng H. Oxidative stress induces monocyte necrosis with enrichment of cell-bound albumin and overexpression of endoplasmic reticulum and mitochondrial chaperones. PLoS ONE. 2013;8(3):e59610\u201321.","journal-title":"PLoS ONE"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-026-03674-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03674-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03674-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:44:29Z","timestamp":1781635469000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-026-03674-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3674"],"URL":"https:\/\/doi.org\/10.1186\/s13046-026-03674-x","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experiments conformed to the guidelines of the Institutional Animal Care and Use Committee of the Xi\u2019an Jiaotong University (Project No. XJTUAE2024-1992). All experimental protocols were approved by the Ethics Committee of Xi\u2019an Jiaotong University Health Science Center.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"110"}}